These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1531566)

  • 1. Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy.
    Leenen FH; Holliwell DL
    Am J Cardiol; 1992 Mar; 69(6):639-45. PubMed ID: 1531566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of left ventricular hypertrophy during long-term antihypertensive treatment--a comparison between felodipine and the combination of felodipine and metoprolol.
    Wetzchewald D; Klaus D; Garanin G; Lohr E; Hoffmann J
    J Intern Med; 1992 Mar; 231(3):303-8. PubMed ID: 1532616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.
    Leenen FH; Coletta E; White R
    J Hypertens; 2006 Jan; 24(1):177-84. PubMed ID: 16331116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.
    Br J Clin Pharmacol; 1988 Nov; 26(5):535-45. PubMed ID: 2905154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients.
    Cerasola G; Cottone S; Nardi E; Fulantelli MA; Carone MB; D'Ignoto G
    J Hum Hypertens; 1990 Dec; 4(6):703-8. PubMed ID: 2151392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
    Fogari R; Zoppi A; Corradi L; Preti P; Malalamani GD; Mugellini A
    J Hypertens; 2000 Dec; 18(12):1871-5. PubMed ID: 11132613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
    Seravalle G; Brambilla G; Pizzalla DP; Casati A; Riva M; Cuspidi C; Bombelli M; Mancia G; Grassi G
    J Am Soc Hypertens; 2016 Mar; 10(3):244-51. PubMed ID: 26831124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.
    Lindqvist M; Kahan T; Melcher A; Hjemdahl P
    Hypertension; 1994 Sep; 24(3):287-96. PubMed ID: 8082934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass.
    Leenen FH; Fourney A
    Am J Cardiol; 1996 Jul; 78(2):203-7. PubMed ID: 8712143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
    Todd PA; Faulds D
    Drugs; 1992 Aug; 44(2):251-77. PubMed ID: 1382018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function.
    Schulman DS; Flores AR; Tugoen J; Dianzumba S; Reichek N
    Am J Cardiol; 1996 Jul; 78(1):56-60. PubMed ID: 8712119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of felodipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: possible interaction with cyclosporine medication.
    Schwitter J; De Marco T; Globits S; Sakuma H; Klinski C; Chatterjee K; Parmley WW; Higgins CB
    J Heart Lung Transplant; 1999 Oct; 18(10):1003-13. PubMed ID: 10561111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rest and effort hemodynamic responses during prolonged treatment with felodipine, 24-h blood pressure monitoring, and echocardiographic changes.
    Zimlichman R; Schwartz J; Tobar R
    Am J Hypertens; 1997 Aug; 10(8):905-12. PubMed ID: 9270086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension.
    Grassi G; Seravalle G; Turri C; Bolla G; Mancia G
    Hypertension; 2003 Mar; 41(3):558-62. PubMed ID: 12623959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?
    Waeber B; Detry JM; Dahlöf B; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Safar M; Tanser P; Toutouzas P
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):915-20. PubMed ID: 10509550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.